Download PDF
CC BY-NC-ND 4.0 · World J Nucl Med 2022; 21(02): 112-119
DOI: 10.1055/s-0042-1750332
Original Article

The Diagnostic Accuracy of 18F-FGD-PET/CT for Cancer of the Gallbladder: A Retrospective Study

Stephanos Pericleous
1   Department of HPB Surgery, Academic Department of Surgery, Royal Marsden Hospital, London, United Kingdom
,
Sophie L. F. Doran
1   Department of HPB Surgery, Academic Department of Surgery, Royal Marsden Hospital, London, United Kingdom
,
Andrew Wotherspoon
2   Department of Histopathology, Royal Marsden Hospital, London, United Kingdom
,
Monica Terlizzo
2   Department of Histopathology, Royal Marsden Hospital, London, United Kingdom
,
Angela Riddell
3   Department of Radiology and Nuclear Medicine, Royal Marsden Hospital, London, United Kingdom
,
Gina Brown
3   Department of Radiology and Nuclear Medicine, Royal Marsden Hospital, London, United Kingdom
,
Joshua Shur
3   Department of Radiology and Nuclear Medicine, Royal Marsden Hospital, London, United Kingdom
,
Sue Chua
3   Department of Radiology and Nuclear Medicine, Royal Marsden Hospital, London, United Kingdom
,
Nabil Hujairi
3   Department of Radiology and Nuclear Medicine, Royal Marsden Hospital, London, United Kingdom
,
Nicos Middleton
4   School of Health Sciences, Cyprus University of Technology, Limassol, Cyprus
,
David Cunningham
5   Department of Oncology, Royal Marsden Hospital, London, United Kingdom
,
Sacheen Kumar
6   Department of Surgery, Academic Department of Surgery, Royal Marsden Hospital, London, United Kingdom
,
Ricky H. Bhogal
1   Department of HPB Surgery, Academic Department of Surgery, Royal Marsden Hospital, London, United Kingdom
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Background Gallbladder cancer has a poor prognosis and imaging can have variable diagnostic accuracy. We assessed the ability of preoperative 18F-fluorodeoxyglucose positron emission tomography computed tomography (18F-FDG-PET/CT) imaging to predict a postoperative histological diagnosis of gallbladder cancer.

Method A retrospective analysis was undertaken in a cohort of patients, who had suspected gallbladder cancer on cross-sectional imaging and that underwent preoperative FDG-PET/CT scan. The discriminatory power of FDG-PET/CT was determined in receiver operator characteristic (ROC) analysis and diagnostic accuracy parameters were estimated at different thresholds of maximum standard unit value (SUVmax).

Results Twenty-two patients were included in the study; 7 had malignant and 15 benign diagnoses. There was no statistically significant difference between the measured SUVmax between the two groups (p = 0.71). With an area under the curve of 0.486, the ROC curve did not indicate any discriminatory power of FDG-PET/CT at any potential threshold of SUVmax.

Conclusion This study indicates that the diagnosis of primary gallbladder cancer cannot be accurately confirmed with FDG PET/CT scanning.

Keywords

gallbladder - FDG - PET - CT - cancer - thickening - cholecystitis - diagnostic accuracy

Authors' Contributions

SP and RHB conceptualized the manuscript. SP and SLFD were involved in data curation. SP and RHB were involved in methodology. SP and NM did formal analysis. AW, MT, AR, GB, JS, SC, and NH validated the data. SP, SLFD, and RHB were involved in write up of original data. SP, AW, MT, AR, GB, JS, SC, NH, DC, SK, and RHB were involved in write-up, review, and editing.




Publication History

Article published online:
19 July 2022

© 2022. World Association of Radiopharmaceutical and Molecular Therapy (WARMTH). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68 (06) 394-424
    Search in Google Scholar
  • 2 Andrén-Sandberg A. Diagnosis and management of gallbladder cancer. N Am J Med Sci 2012; 4 (07) 293-299
    CrossrefPubMedSearch in Google Scholar
  • 3 Kalra N, Gupta P, Singhal M. et al. Cross-sectional imaging of gallbladder carcinoma: an update. J Clin Exp Hepatol 2019; 9 (03) 334-344
    CrossrefPubMedSearch in Google Scholar
  • 4 Meng H, Wang X, Fong Y, Wang Z-H, Wang Y, Zhang Z-T. Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases. Jpn J Clin Oncol 2011; 41 (08) 992-998
    CrossrefPubMedSearch in Google Scholar
  • 5 Bertran E, Heise K, Andia ME, Ferreccio C. Gallbladder cancer: incidence and survival in a high-risk area of Chile. Int J Cancer 2010; 127 (10) 2446-2454
    CrossrefPubMedSearch in Google Scholar
  • 6 Furlan A, Ferris JV, Hosseinzadeh K, Borhani AA. Gallbladder carcinoma update: multimodality imaging evaluation, staging, and treatment options. AJR Am J Roentgenol 2008; 191 (05) 1440-1447
    CrossrefPubMedSearch in Google Scholar
  • 7 Yadav R, Jain D, Mathur SR, Sharma A, Iyer VK. Gallbladder carcinoma: an attempt of WHO histological classification on fine needle aspiration material. Cytojournal 2013; 10: 12
    CrossrefPubMedSearch in Google Scholar
  • 8 Gupta P, Kumar M, Sharma V, Dutta U, Sandhu MS. Evaluation of gallbladder wall thickening: a multimodality imaging approach. Expert Rev Gastroenterol Hepatol 2020; 14 (06) 463-473
    CrossrefPubMedSearch in Google Scholar
  • 9 Garg PK, Pandey D, Sharma J. The surgical management of gallbladder cancer. Expert Rev Gastroenterol Hepatol 2015; 9 (02) 155-166
    CrossrefPubMedSearch in Google Scholar
  • 10 Sternby Eilard M, Lundgren L, Cahlin C, Strandell A, Svanberg T, Sandström P. Surgical treatment for gallbladder cancer - a systematic literature review. Scand J Gastroenterol 2017; 52 (05) 505-514
    CrossrefPubMedSearch in Google Scholar
  • 11 Rodríguez-Fernández A, Gómez-Río M, Llamas-Elvira JM. et al. Positron-emission tomography with fluorine-18-fluoro-2-deoxy-D-glucose for gallbladder cancer diagnosis. Am J Surg 2004; 188 (02) 171-175
    CrossrefPubMedSearch in Google Scholar
  • 12 Ramos-Font C, Gómez-Rio M, Rodríguez-Fernández A, Jiménez-Heffernan A, Sánchez Sánchez R, Llamas-Elvira JM. Ability of FDG-PET/CT in the detection of gallbladder cancer. J Surg Oncol 2014; 109 (03) 218-224
    CrossrefPubMedSearch in Google Scholar
  • 13 Boellaard R, Delgado-Bolton R, Oyen WJG. et al; European Association of Nuclear Medicine (EANM). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 2015; 42 (02) 328-354
    CrossrefPubMedSearch in Google Scholar
  • 14 D'Angelica M, Dalal KM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol 2009; 16 (04) 806-816
    CrossrefPubMedSearch in Google Scholar
  • 15 Kitagawa Y, Nishizawa S, Sano K. et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 2003; 44 (02) 198-206
    PubMedSearch in Google Scholar
  • 16 Kubota K, Yokoyama J, Yamaguchi K. et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004; 31 (04) 590-595
    CrossrefPubMedSearch in Google Scholar
  • 17 Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 2004; 8 (01) 90-97
    CrossrefPubMedSearch in Google Scholar
  • 18 Oe A, Kawabe J, Torii K. et al. Distinguishing benign from malignant gallbladder wall thickening using FDG-PET. Ann Nucl Med 2006; 20 (10) 699-703
    CrossrefPubMedSearch in Google Scholar
  • 19 Lee SW, Kim HJ, Park JH. et al. Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterol 2010; 45 (05) 560-566
    CrossrefPubMedSearch in Google Scholar
  • 20 Ma KW, Cheung TT, She WH. et al. Diagnostic and prognostic role of 18-FDG PET/CT in the management of resectable biliary tract cancer. World J Surg 2018; 42 (03) 823-834
    CrossrefPubMedSearch in Google Scholar
  • 21 Kim J, Ryu JK, Kim C, Paeng JC, Kim Y-T. Is there any role of positron emission tomography computed tomography for predicting resectability of gallbladder cancer?. J Korean Med Sci 2014; 29 (05) 680-684
    CrossrefPubMedSearch in Google Scholar
  • 22 Benson AB, D'Angelica MI, Abbott DE. et al. Guidelines insights: hepatobiliary cancers, version 2.2019. J Natl Compr Canc Netw 2019; 17 (04) 302-310
    CrossrefPubMedSearch in Google Scholar
  • 23 Valle JW, Borbath I, Khan SA, Huguet F, Gruenberger T, Arnold D. ESMO Guidelines Committee. Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016; 27 (Suppl. 05) v28-v37
    CrossrefPubMedSearch in Google Scholar
  • 24 Evidence-based indications for the use of PET-CT in the United Kingdom. 2016 The Royal College of Radiologists [Internet]. [cited 2020 Oct 11]; Accessed April 1, 2022 from: https://www.rcr.ac.uk/publication/evidence-based-indications-use-pet-ct-united-kingdom-2016
    PubMedSearch in Google Scholar